REFERENCES
- Lachmann HJ, Hawkins PN. Amyloidosis and the lung. Chron Respir Dis. 2006;3:203–214.
- Meeus G, Ponette J, Delabie J, Verschakelen J, Blockmans D. Immunoglobulin related amyloidosis presenting as isolated lymph node and pulmonary involvement. Leuk Lymphoma. 2000;38:423–427.
- Vitolo U, Ferreri AJM, Montoto S. Lymphoplasmacytic lymphoma-Waldenstrom’s macroglobulinemia. Crit Rev Oncol Hematol. 2008;67:172–185.
- Waldenström J. Incipient myelomatosis or “essential” hyperglobulinemia with fibrinogenopenia: A new syndrome? Acta Med Scand. 1944;117:216–247.
- Cohen AD, Zhou P, Xiao Q, . Systemic AL amyloidosis due to non-Hodgkin’s lymphoma: An unusual clinicopathologic association. Br J Hematol. 2004;124:309–314.
- Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med. 1990; 112:455–464.
- Eguchi T, Yoshida K, Kobayashi N, . Localized nodular amyloidosis of the lung. Gen Thorac Cardiovasc Surg. 2011;59:715–717.
- Kyle RA, Therneau TM, Rajkumar SV, . Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003;102:3759–3764.
- Stone MJ. Waldenström’s macroglobulinemia: Hyperviscosity syndrome and cryoglobulinemia. Clin Lymphoma Myeloma. 2009;9:97–99.
- Kyrtsonis MC, Angelopoulou MK, Kontopidou FN, . Primary lung involvement in Waldenström’s macroglobulinemia report of two cases and review of the literature. Acta Hematol. 2001;105:92–96.
- Okuda M, Okuda Y, Ogura T, . Primary lung involvement with amyloid deposition in Waldenström’s macroglobulinemia: Observations from over 20 years. Respirology. 2004; 9:414–418.
- Stedman J, Roccaro A, Leleu X, Ghobrial IM. New therapeutic approaches for Waldenstrom macroglobulinemia. Drugs Future. 2010;35:53–58.
- Treon SP. How I treat Waldenström macroglobulinemia. Blood. 2009;114:2375–2385.
- García-Sanz R, Ocio EM. Novel treatment regimens for Waldenström’s macroglobulinemia. Expert Rev Hematol. 2010;3:339–350.